This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as Hybrid Event from September 20-30, 2021
Live In-Person Experience Delivered September 20-23Boston Convention and Exhibition Center

Ichiro Mori, PhD
Director of R&D at NATiAS Inc.

Profile

Dr. Mori is Director of R&D of NATiAS since 2021 and a visiting professor at Kobe University Graduate School of Science, Technology and Innovation. Prior to NATiAS, he started his carrier as medicinal chemist at Novartis and GSK, and moved to Pfizer as a director of chemistry department at the Nagoya site in Japan. After nearly 20 years’ experience in pharmaceutical industry, he then moved to Kobe University as a professor working on drug discovery projects. He received his M.S. from Kyoto University and Ph.D. from U.C. Berkeley. He was a postdoc with Prof. Rick Danheiser at Massachusetts Institute of Technology and a visiting scholar with Prof. Christopher Walsh at Harvard Medical School.

Agenda Sessions

  • Liquid-phase Synthesis (LPS) of Oligonucleotide by Using Blockmer™

    9:15am

Speakers at this event